Work

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412

Year: 2002

Type: article

Source: Cancer Cell

DOI: 10.1016/s1535-6108(02)00069-7

Authors: Ellen Weisberg, Christina Boulton, Louise M Kelly, Paul Manley, Doriano Fabbro, Thomas Meyer, D.Gary Gilliland, James D Griffin

Institutions: Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard University, Novartis (Switzerland)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Howard Hughes Medical Institute, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Abnormalities/Signal Transduction/Hematopoietic Disease, Development of Novel Therapeutic Strategies in Human Leukemias

OpenAlex ID: W1983999811

FWCI: 21.89

Cites: 38

Cited by: 611

Related to: 8